I

Instituto Especialidades de la Salud Rosario | Centro de Investigacion Clinica

Research site

(Unclaimed)

Location

Espana 931, Rosario, Santa Fe, Argentina

Site insights

Top conditions

Top treatments

LY3298176

LY3502970

Orforglipron

Tirzepatide

Metformin

MSTT1041A

Povorcitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 4 total trials

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin (ACHIEVE-3)

The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes a...

Active, not recruiting

Type 2 Diabetes

Drug: Semaglutide

Drug: Orforglipron

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO)

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting

Overweight

Obesity

Drug: Placebo

Drug: Tirzepatide